FI119353B - Hitaasti vapauttava täyteaine - Google Patents

Hitaasti vapauttava täyteaine Download PDF

Info

Publication number
FI119353B
FI119353B FI956209A FI956209A FI119353B FI 119353 B FI119353 B FI 119353B FI 956209 A FI956209 A FI 956209A FI 956209 A FI956209 A FI 956209A FI 119353 B FI119353 B FI 119353B
Authority
FI
Finland
Prior art keywords
filler
delayed release
crosslinking agent
heteropolysaccharide
dosage form
Prior art date
Application number
FI956209A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI956209A (fi
FI956209A0 (fi
Inventor
Anand R Baichwal
Troy W Mccall
Original Assignee
Penwest Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Penwest Pharmaceuticals Co filed Critical Penwest Pharmaceuticals Co
Publication of FI956209A publication Critical patent/FI956209A/fi
Publication of FI956209A0 publication Critical patent/FI956209A0/fi
Application granted granted Critical
Publication of FI119353B publication Critical patent/FI119353B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Character Spaces And Line Spaces In Printers (AREA)
  • Superstructure Of Vehicle (AREA)
  • Push-Button Switches (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI956209A 1994-04-25 1995-12-22 Hitaasti vapauttava täyteaine FI119353B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23262594A 1994-04-25 1994-04-25
US23262594 1994-04-25
US9503825 1995-03-21
PCT/US1995/003825 WO1995028916A1 (en) 1994-04-25 1995-03-21 Sustained release excipient

Publications (3)

Publication Number Publication Date
FI956209A FI956209A (fi) 1995-12-22
FI956209A0 FI956209A0 (fi) 1995-12-22
FI119353B true FI119353B (fi) 2008-10-31

Family

ID=22873888

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956209A FI119353B (fi) 1994-04-25 1995-12-22 Hitaasti vapauttava täyteaine

Country Status (18)

Country Link
EP (2) EP0706377B1 (zh)
JP (1) JP3279318B2 (zh)
KR (1) KR100232020B1 (zh)
CN (1) CN1131023C (zh)
AT (2) ATE308318T1 (zh)
AU (1) AU705378B2 (zh)
CA (1) CA2164513C (zh)
DE (2) DE69534575T2 (zh)
DK (1) DK0706377T3 (zh)
ES (2) ES2246961T3 (zh)
FI (1) FI119353B (zh)
HK (1) HK1040487B (zh)
HU (1) HU219818B (zh)
IL (1) IL113167A (zh)
MX (1) MX9600022A (zh)
PT (1) PT706377E (zh)
TW (1) TW357085B (zh)
WO (1) WO1995028916A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096834A (en) * 1997-04-04 2000-08-01 Monsanto Company Hydrolyzable delivery system using crosslinked polymeric resins as vehicles
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
AU6783498A (en) 1997-04-04 1998-10-30 Monsanto Company Ph-selective delivery system using cross-linked polymeric resins as vehicles
CA2452871C (en) 2001-07-06 2011-10-04 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
US20030091635A1 (en) * 2001-09-26 2003-05-15 Baichwal Anand R. Opioid formulations having reduced potential for abuse
AU2003230805A1 (en) * 2002-04-05 2003-10-27 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
KR101999055B1 (ko) * 2018-02-28 2019-10-01 경북대학교 산학협력단 과황산 이온 서방성 구조체, 이의 제조방법 및 이를 이용한 유기 오염 물질 처리 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303691A (en) * 1977-11-09 1981-12-01 Anderson, Clayton & Co. Proteinaceous food product
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form

Also Published As

Publication number Publication date
FI956209A (fi) 1995-12-22
IL113167A0 (en) 1995-06-29
JPH08512061A (ja) 1996-12-17
ES2164764T3 (es) 2002-03-01
EP1145712B1 (en) 2005-11-02
TW357085B (en) 1999-05-01
AU2198295A (en) 1995-11-16
EP0706377A4 (en) 1996-11-06
HK1040487A1 (en) 2002-06-14
ES2246961T3 (es) 2006-03-01
WO1995028916A1 (en) 1995-11-02
DE69524358D1 (de) 2002-01-17
DE69524358T2 (de) 2002-06-13
JP3279318B2 (ja) 2002-04-30
DE69534575D1 (de) 2005-12-08
ATE308318T1 (de) 2005-11-15
CN1127469A (zh) 1996-07-24
CA2164513A1 (en) 1995-11-02
DK0706377T3 (da) 2002-04-02
KR100232020B1 (ko) 1999-12-01
EP1145712A1 (en) 2001-10-17
AU705378B2 (en) 1999-05-20
FI956209A0 (fi) 1995-12-22
DE69534575T2 (de) 2006-07-13
HUT73636A (en) 1996-08-28
CN1131023C (zh) 2003-12-17
EP0706377B1 (en) 2001-12-05
HK1040487B (zh) 2006-05-12
HU9503456D0 (en) 1996-02-28
EP0706377A1 (en) 1996-04-17
KR960703016A (ko) 1996-06-19
CA2164513C (en) 1999-09-21
IL113167A (en) 2001-01-28
HU219818B (hu) 2001-08-28
PT706377E (pt) 2002-05-31
ATE209906T1 (de) 2001-12-15
MX9600022A (es) 1998-06-30

Similar Documents

Publication Publication Date Title
FI118001B (fi) Kerran päivässä suun kautta otettava metoprololiannosmuoto
KR100264024B1 (ko) 서방성 제형(알부테롤)
FI116450B (fi) Menetelmä valmistaa metoprololin 24 tunnin valmistetta
KR100321489B1 (ko) 고용량의불용성약물용서방성매트릭스
EP0360562B2 (en) Directly compressible sustained release excipient
WO1997016172A9 (en) Controlled release formulation (albuterol)
FI119353B (fi) Hitaasti vapauttava täyteaine
MXPA96000024A (en) Form of oral dosing of metoprolol one time
MXPA94008792A (en) Sustained release formulations for 24 hours of metopro release

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119353

Country of ref document: FI

MM Patent lapsed